Spontaneous Urticaria
📧 Sign up to get email alerts when something new happens for Spontaneous Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-09Clinical Trial Update: Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria [Phase 2]
A Phase 2 trial of Ritlecitinib (PF-06651600) for chronic spontaneous urticaria has been withdrawn.